Eurocine Vaccines is a pharmaceutical company. The company develops vaccines using its proprietary technology platform Endocine™, which vaccines are subsequently licensed to partners for further development and commercialization. Development is carried out in cooperation with other companies in the industry. The technology platform Endocine™ is also offered to other companies for development within certain indications. The head office is located in Solna.

Quotes for Eurocine Vaccines AB

Right Now

+/-
-0.15
%
-12,50%
Latest
1.05
High
1.2
Low
0.814
Volume
277 682
Turnover (SEK)
279 766
Market Value (MSEK)
18,2
Time (Latest trade)

Board

CEO

  • Hans Arwidsson

Chairperson of the Board

  • Pierre Morgon

Board

  • Emanuele Montomoli
  • Hans Arwidsson
  • Jan Sandström
  • Pär Thuresson

Videos

Largest Owners

Name Capital % Votes % Date
Thomas Eldered 16,12 16,12 2022-06-28
Avanza Pension 6,37 6,37 2022-06-28
Nordnet Pensionsförsäkring 4,62 4,62 2022-06-28
Jan Kenneth Karjalainen 1,30 1,30 2022-06-28
Göran Erlandsson 1,28 1,28 2022-06-28
Kent Olsson 1,19 1,19 2022-06-28
Johann Bech Vedsmand 0,92 0,92 2022-06-28
Mats Kenneth Pettersson 0,89 0,89 2022-06-28
Bo Sjögren 0,86 0,86 2022-06-28
VisMederi Srl 0,79 0,79 2022-06-28
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-11-29 Delårsrapport 2023-Q1

  • 2022-12-21 Årsstämma 2022